These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8641311

  • 1. Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
    Gimeno C, Navarro D, Savall F, Millás E, Farga MA, Garau J, Cisterna R, García-de-Lomas J.
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):82-5. PubMed ID: 8641311
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.
    Pérez FJ, Navarro D, Gimeno C, García-de-Lomas J.
    Chemotherapy; 1997 Jan; 43(1):27-30. PubMed ID: 8996738
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F, Quentin C.
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G, Marchetti F.
    Chemotherapy; 2000 Feb; 46(4):229-34. PubMed ID: 10859428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
    Metan G, Zarakolu P, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2006 Feb; 40(1-2):23-8. PubMed ID: 16775953
    [Abstract] [Full Text] [Related]

  • 9. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Feb; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 10. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
    Arita K, Daido K, Ohashi N, Nakamura K, Takeshima Y, Kohara T.
    Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928
    [Abstract] [Full Text] [Related]

  • 11. Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.
    Blondeau JM, Suter ME, Borsos S, Misfeldt C.
    Int J Antimicrob Agents; 1998 Nov; 10(4):297-302. PubMed ID: 9916904
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
    Trautmann M, Heinemann M, Zick R, Möricke A, Seidelmann M, Berger D.
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):754-60. PubMed ID: 9923514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
    Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA.
    Clin Infect Dis; 1996 Oct; 23(4):779-84. PubMed ID: 8909844
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.
    Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2248-52. PubMed ID: 8619577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.